1 / 36

Expert Insights on Emerging Data from the 2014 Global Congress on MS

Expert Insights on Emerging Data from the 2014 Global Congress on MS. Program Goals. Disclaimers. Current Clinical Data on New and Emerging MS Disease-Modifying Therapies. Glatiramer Acetate. Dimethyl Fumarate. Pegylated Interferon. Daclizumab HYP. Daclizumab HYP MRI Results.

oliver-nichols
Download Presentation

Expert Insights on Emerging Data from the 2014 Global Congress on MS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Expert Insights on Emerging Data from the 2014 Global Congress on MS

  2. Program Goals

  3. Disclaimers

  4. Current Clinical Data on New and Emerging MS Disease-Modifying Therapies

  5. Glatiramer Acetate

  6. Dimethyl Fumarate

  7. Pegylated Interferon

  8. Daclizumab HYP

  9. Daclizumab HYPMRI Results

  10. You must view all 3 sections of this activity to earn CME credit.Please click on the next section title to continue.

  11. Biomarkers, Safety, and New Treatment Targets

  12. MS Therapy Is Cost-effective

  13. Biomarkers of Treatment ResponseAnalysis by Dhib-Jalbut

  14. Biomarkers of Treatment ResponseAnalysis by Dhib-Jalbut (cont)

  15. NatalizumabStopping Treatment

  16. Natalizumab (cont) PML

  17. Natalizumab (cont)Extended Dosing

  18. PML Risk With Other DMTs

  19. MS Management Algorithms

  20. NEDA

  21. You must view all 3 sections of this activity to earn CME credit.Please click on the next section title to continue.

  22. On the Horizon

  23. RemyelinationAnti-LINGO

  24. RemyelinationHistamine 3 Receptor Agonist

  25. Neuroprotection

  26. Other Therapies on the Horizon

  27. Other Therapies on the Horizon (cont)

  28. Abbreviations

  29. Abbreviations (cont)

  30. References

  31. References (cont)

  32. References (cont)

  33. References (cont)

  34. References (cont)

  35. References (cont)

  36. References (cont)

More Related